Premium
Chronic kidney disease epidemic: How do we deal with it?
Author(s) -
Ng Jack KC,
Li Philip KT
Publication year - 2018
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.13464
Subject(s) - medicine , intensive care medicine , kidney disease , peritoneal dialysis , dialysis , disease , intervention (counseling) , diabetes mellitus , population , quality of life (healthcare) , hemodialysis , clinical trial , environmental health , nursing , endocrinology
Chronic kidney disease (CKD) is a leading cause of mortality and morbidity around the world. The prevalence of CKD increases steadily over the past decade in parallel to the rapid expansion of diabetic population. Apart from increased mortality, CKD also has significant impact on quality of life and the economy. The approach to deal with the global CKD epidemic is multifaceted. Early detection by screening high‐risk individuals such as those with hypertension and diabetes is important and cost‐effective. However, low CKD awareness in many countries may impose barriers to early intervention. Hence raising CKD awareness among public and policy makers should be encouraged. In addition, the use of peritoneal dialysis, a less costly and home‐based dialysis modality compared with in‐center haemodialysis, should be promoted to maximize access to dialysis with limited resources. Finally, ongoing research and clinical trials through international collaborations could provide further insight into the pathophysiology of CKD progression, and establish the foundation for development of specific therapeutic agents to retard progression to end stage renal failure.